Adverse Events Associated With Antibody-Drug Conjugates Across Cancer Types
Researchers say they have identified adverse events that are more likely to occur in cancer patients receiving antibody-drug conjugates.
Researchers say they have identified adverse events that are more likely to occur in cancer patients receiving antibody-drug conjugates.
Local therapy improves overall survival in patients with clinically lymph node-positive prostate cancer, a meta-analysis suggests.
There was a decrease in new cancer diagnoses, relative to expected numbers, between March 2020 and May 2020, according to a report.
Diabetes increases the likelihood of upstaging in patients with clinical T1 RCC undergoing partial or radical nephrectomy, a study suggests.
In a recent survey, 70% of cancer patients said they use complementary or alternative medicine as part of their cancer care.
Researchers say they have identified genes that should be considered for gene panel testing in prostate cancer.
Privately-insured cancer patients living in states with restrictive telehealth policies were less likely to use telehealth in 2020 and 2021, a study showed.
Investigators tested a less aggressive chemoradiation protocol in patients with MIBC who were unfit for surgery due to age or comorbidities.
Comparing Medicare Part D plans can reduce financial toxicity associated with the use of oral androgen inhibitors in patients with advanced prostate cancer, a study suggests.
As currently defined, biochemical recurrence after surgery or radiation is not a reliable predictor of the risk of death from prostate cancer, investigators say.